RSV activity is higher-than-normal into spring, prompting Michigan and multiple states to extend immunization timelines. Expect modest, localized increases in demand for RSV vaccines and immunization services and potential short-term pressure on pediatric and respiratory care capacity, but this is unlikely to move broader markets.
RSV activity is higher-than-normal into spring, prompting Michigan and multiple states to extend immunization timelines. Expect modest, localized increases in demand for RSV vaccines and immunization services and potential short-term pressure on pediatric and respiratory care capacity, but this is unlikely to move broader markets.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00